Phase 3 Renal Disease Clinical Trials
9 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–9 of 9 trials
Recruiting
Phase 3
Efficacy and Safety of XyloCore Peritoneal Dialysis Solution.
End Stage Renal Disease
Iperboreal Pharma Srl170 enrolled41 locationsNCT03994471
Recruiting
Phase 2Phase 3
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
End Stage Renal Disease
Roberto Gedaly78 enrolled1 locationNCT03321656
Recruiting
Phase 3
A Phase 3 Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults at High Risk of Delayed Graft Function (DGF) Following Kidney Allograft Transplantation
End Stage Renal DiseaseDelayed Graft FunctionDeceased Donor Kidney Transplant
Apellis Pharmaceuticals, Inc.320 enrolled1 locationNCT07020832
Recruiting
Phase 3
A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China
HyperphosphatemiaDialysisChronic Kidney Disease, Receiving Dialysis+1 more
Alebund Pharmaceuticals264 enrolled42 locationsNCT06933472
Recruiting
Phase 3
Maintaining or Stopping Immunosuppressive Therapy in Patients With ANCA Vasculitis and End-stage Renal Disease
Anti-Neutrophil Cytoplasmic Antibody-Associated VasculitisEnd Stage Renal Disease
Centre Hospitalier Departemental Vendee136 enrolled58 locationsNCT03323476
Recruiting
Phase 3
CoQ10 and Exercise for Mitochondrial Dysfunction in Advance Kidney Disease
End Stage Renal Disease
Vanderbilt University Medical Center156 enrolled2 locationsNCT05422534
Recruiting
Phase 3
To Compare the Efficacy and Safety of the ATEV With AVF in Female Patients With End-Stage Renal Disease Requiring Hemodialysis
End Stage Renal Disease (ESRD)
Humacyte, Inc.150 enrolled32 locationsNCT05908084
Active
Phase 3
Effect of angiotensin receptor blockers on blood pressure control among euvolemic hypertensive hemodialysis patients: a randomized controlled trial
hypertension in End stage renal disease
Universiti Sains Malaysia88 enrolled1 locationACTRN12615001322527
Completed
Phase 3
Human Papilloma Virus (HPV) Vaccination in Special Risk Groups
Special Risk Groups
1. Paediatric Rheumatalogical Disease
2. Inflammatory Bowel Disease
3. Acute Lymphoblastic Leukaemia
4. Solid Organ Transplant Recipients (kidney and liver)
5. Chronic Renal Disease
6. Bone Marrow Transsplant
The response to the HPV vaccine will be studied within these 6 special risk groups.
National Health and Medical Research Council & Clinical Centre of Research Excellence(NHMRC CCRE) in Childhood and Adolescent Immunisation100 enrolled1 locationACTRN12609000571279